Biblio Discovery — Demo Discovery Service

123 results for "Demoly Pascal"

Showing 21–40 · 1.14 seconds · RSS

  1. Journal Article Full text

    Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back

    Schrijvers, Rik; Gilissen, Liesbeth; Chiriac, Anca Mirela et al.

    Clin Transl Allergy · 2015 · English · PubMed Central

    Drug hypersensitivity reactions (DHR) have been present since the advent of drugs. In particular T-cell mediated delayed-type hypersensitivity reactions represent a heterogeneous clinical entity with a diverse pathogenesis and result in a considerable burden of morbidity and mortality not only…

  2. Journal Article Full text

    A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis

    Devillier, Philippe; Dreyfus, Jean-François; Demoly, Pascal et al.

    BMC Med · 2014 · English · PubMed Central

    BACKGROUND: The capacity of sublingual allergen immunotherapy (SLIT) to provide effective symptom relief in pollen-induced seasonal allergic rhinitis is often questioned, despite evidence of clinical efficacy from meta-analyses and well-powered, double-blind, placebo-controlled randomized clinical…

  3. Journal Article Full text

    Management of the polyallergic patient with allergy immunotherapy: a practice-based approach

    Demoly, Pascal; Passalacqua, Giovanni; Pfaar, Oliver et al.

    Allergy Asthma Clin Immunol · 2016 · English · PubMed Central

    BACKGROUND: The great majority (60–80 %) of patients consulting specialist physicians for allergic respiratory disease are polysensitized and thus may be potentially clinically polyallergic. However, management approaches to allergen immunotherapy (AIT) in polysensitized and polyallergic patients…

  4. Journal Article Full text

    Patient engagement and patient support programs in allergy immunotherapy: a call to action for improving long-term adherence

    Demoly, Pascal; Passalacqua, Giovanni; Pfaar, Oliver et al.

    Allergy Asthma Clin Immunol · 2016 · English · PubMed Central

    Allergy immunotherapy (AIT) is acknowledged to produce beneficial mid- and long-term clinical and immunologic effects and increased quality of life in patients with allergic respiratory diseases (such as allergic rhinoconjunctivitis and allergic asthma). However, poor adherence to AIT (due to…

  5. Journal Article Full text

    Mapping hypersensitivity/allergic diseases in the International Classification of Diseases (ICD)-11: cross-linking terms and unmet needs

    Tanno, Luciana Kase; Calderon, Moises; Papadopoulos, Nikolaos G. et al.

    Clin Transl Allergy · 2015 · English · PubMed Central

    BACKGROUND: With the aim of actively contributing to the ongoing 11(th) International Classification of Diseases (ICD) revision, an international collaboration led by the European Academy of Allergy and Clinical Immunology (EAACI) has decided to revise the classification of…

  6. Journal Article Full text

    Exploring the pathogenesis and clinical implications of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap (ACO): a narrative review

    Simmalee, Kantapat; Kawamatawong, Theerasuk; Vitte, Joana et al.

    Front Med (Lausanne) · 2025 · English · PubMed Central

    The complexity and diversity of the immune response in patients with asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap present significant challenges for disease management. Relying on a limited number of biomarkers and clinical data is insufficient to fully reveal the…

  7. Journal Article Full text

    Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic()

    Devillier, Philippe; Saf, Sarah; Rolland, Christine et al.

    World Allergy Organ J · 2024 · English · PubMed Central

    BACKGROUND: The COVID-19 pandemic brought unprecedented global disruption to both healthcare providers and patients with respiratory allergies. There are limited real-life data on the impact of the COVID-19 pandemic on the risk perception of patients with allergy treated with allergen immunotherapy…

  8. Journal Article Full text

    SARS-CoV-2 Vaccination and Anaphylaxis: Recommendations of the French Allergy Community and the Montpellier World Health Organization Collaborating Center

    Tanno, Luciana Kase; Berard, Frédéric; Beaudoin, Etienne et al.

    Vaccines (Basel) · 2021 · English · PubMed Central

    Vaccines against COVID-19 (and its emerging variants) are an essential global intervention to control the current pandemic situation. Anaphylactic reactions have been reported after SARS-CoV2 RNA vaccines. Anaphylaxis is defined as a severe life-threatening generalized or systemic hypersensitivity…

  9. Journal Article Full text

    Anaphylaxis severity grade, during oral food challenges, assessed by five different classifications

    Bouderbala, Yanis; Clark, Evangéline; Tanno, Luciana Kase et al.

    Pediatr Allergy Immunol · 2025 · English · PubMed Central

    BACKGROUND: While the definition of anaphylaxis is clear, its grade of severity remains a subject of debate. The objective of this study was to evaluate the possible discrepancies in the severity scoring system for anaphylaxis in patients with a positive food challenge (OFC), differentiating…

  10. Journal Article Full text

    Real‐Life Clinical Experience With SQ Grass, Tree, Ragweed, and House Dust Mite Sublingual Immunotherapy Tablets: A Review of Evidence From Non‐Interventional Studies

    Pfaar, Oliver; Janson, Christer; Horn, Andreas et al.

    Allergy · 2025 · English · PubMed Central

    This review evaluates data from > 12,000 children, adolescents and adults (≥ 4 years) in non‐interventional studies to assess the real‐life effectiveness and safety of SQ sublingual immunotherapy (SLIT)‐tablets for allergic rhinitis (AR). Non‐interventional studies of SQ grass, tree, ragweed, and…

  11. Journal Article Full text

    Effect of the Use of Intranasal Spray of Essential Oils in Patients with Perennial Allergic Rhinitis: A Prospective Study

    Caimmi, Davide; Neukirch, Catherine; Louis, Renaud et al.

    Int Arch Allergy Immunol · 2020 · English · PubMed Central

    INTRODUCTION: Among allergic rhinitis (AR) symptoms, nasal obstruction particularly affects the quality of life. Antihistamines and intranasal corticosteroids are the most frequently prescribed symptomatic drugs, but their efficacy is often incomplete. Essential oils (EO) have shown an…

  12. Journal Article Full text

    Efficacy of a Non-Pharmacological Intervention in Seasonal Allergic Rhinitis Symptoms

    Caimmi, Davide; Clark, Evangéline; Fogel, Paul et al.

    Int Arch Allergy Immunol · 2023 · English · PubMed Central

    BACKGROUND: Patients suffering from allergic rhinitis seek for several therapeutic symptomatic options, including nonconventional treatments, to control their symptoms. OBJECTIVES: Through the present proof-of-concept study, we prospectively investigated the potential role of Puressentiel(®) nasal…

  13. Journal Article Full text

    Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics

    Caimmi, Silvia; Sanfiorenzo, Céline; Caimmi, Davide et al.

    Clin Transl Allergy · 2012 · English · PubMed Central

    BACKGROUND: In the general population, reports on suspected ß-lactam hypersensitivity are common. After a drug allergy work-up at best 20% of the selected patients are positive. However, these considerations have not been explored in cystic fibrosis patients for whom antibiotics are even more…

  14. Journal Article Full text

    Discriminating severe seasonal allergic rhinitis. Results from a large nation-wide database

    Caimmi, Davide; Baiz, Nour; Sanyal, Shreosi et al.

    PLoS One · 2018 · English · PubMed Central

    Allergic rhinitis (AR) is a chronic disease affecting a large amount of the population. To optimize treatment and disease management, it is crucial to detect patients suffering from severe forms. Several tools have been used to classify patients according to severity: standardized questionnaires…

  15. Journal Article Full text

    Collaboration between specialties for respiratory allergies in the International Classification of Diseases (ICD)-11

    Tanno, Luciana Kase; Calderon, Moises; Linzer, Jeffrey F. et al.

    Respir Res · 2017 · English · PubMed Central

    BACKGROUND: The International Classification of Diseases (ICD) has been grouping the allergic and hypersensitivity disorders involving the respiratory tract under topographic distribution, regardless of the underlying mechanisms, triggers or concepts currently in use for allergic and…

  16. Journal Article Full text

    Evaluation of patients’ expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index – the benefica study

    Demoly, Pascal; Aubier, Michel; de Blay, Frédéric et al.

    Allergy Asthma Clin Immunol · 2015 · English · PubMed Central

    BACKGROUND: Symptoms of allergic rhinitis (AR) have a detrimental effect on quality of life. The AR-Patient Benefit Index (AR-PBI), a specific self-assessment tool has been developed to assess treatment-related benefit in two separate sections: the Patient Needs Questionnaire (PNQ) which explores…

  17. Journal Article Full text

    “The value of pre- and co-seasonal sublingual immunotherapy in pollen-induced allergic rhinoconjunctivitis”

    Demoly, Pascal; Calderon, Moises A; Casale, Thomas B et al.

    Clin Transl Allergy · 2015 · English · PubMed Central

    Allergen immunotherapy (AIT) is a guidelines-approved, disease-modifying treatment option for respiratory allergies, including allergic rhinitis (AR) induced by pollen. The various AIT regimens employed to date in pollen-induced AR can be classified as continuous (i.e. year-round) or discontinuous…

  18. Journal Article Full text

    IgE-mediated allergy to proton pump inhibitors with both delayed and immediate onset

    Barakat, Leyla; Vasconcelos, Maria João; Bourrain, Jean Luc et al.

    Asia Pac Allergy · 2019 · English · PubMed Central

    Proton pump inhibitors (PPIs) are widely used for the treatment of gastrointestinal diseases. Incidence of drug hypersensitivity reactions (DHRs) to PPIs has been rising, presumably because of their increased consumption. Most DHR are IgE-mediated, with half of the reactions being anaphylactic. We…

  19. Journal Article Full text

    Anaphylaxis in Brazil between 2011 and 2019

    Tanno, Luciana Kase; Molinari, Nicolas; Annesi‐Maesano, Isabella et al.

    Clin Exp Allergy · 2022 · English · PubMed Central

    BACKGROUND: There is a lack of population‐based studies of anaphylaxis from low‐ and middle‐income countries. This hampers public health planning and investments and may influence availability of adrenaline auto‐injectors. OBJECTIVE: We conducted the first national population‐based study of…